These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 3429387)

  • 1. An in-vitro comparison of the intraphagocytic bioactivity of erythromycin and roxithromycin.
    Anderson R; Van Rensburg CE; Jooné G; Lukey PT
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():57-68. PubMed ID: 3429387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro investigation of the intracellular bioactivity of amoxicillin, clindamycin, and erythromycin for Staphylococcus aureus.
    Anderson R; Joone G; van Rensburg CE
    J Infect Dis; 1986 Mar; 153(3):593-600. PubMed ID: 3950443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent.
    Anderson R; Joone G; van Rensburg CE
    J Antimicrob Chemother; 1988 Dec; 22(6):923-33. PubMed ID: 2977384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells.
    Carlier MB; Zenebergh A; Tulkens PM
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():47-56. PubMed ID: 3429386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the in-vitro uptake, intraphagocytic biological activity and effects on neutrophil superoxide generation of dirithromycin compared with erythromycin.
    Jooné GK; Van Rensburg CE; Anderson R
    J Antimicrob Chemother; 1992 Oct; 30(4):509-23. PubMed ID: 1337069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro.
    Labro MT; Amit N; Babin-Chevaye C; Hakim J
    Antimicrob Agents Chemother; 1986 Jul; 30(1):137-42. PubMed ID: 3019233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial activity of roxithromycin: a laboratory evaluation.
    Chantot JF; Bryskier A; Gasc JC
    J Antibiot (Tokyo); 1986 May; 39(5):660-8. PubMed ID: 3733515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
    King A; Phillips I
    Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.
    Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1987 Feb; 31(2):343-5. PubMed ID: 2952064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of azithromycin, roxithromycin and erythromycin on human polymorphonuclear leukocyte function against Staphylococcus aureus.
    Pascual A; López-López G; Aragón J; Perea EJ
    Chemotherapy; 1990; 36(6):422-7. PubMed ID: 1963394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation.
    Anderson R
    J Infect Dis; 1989 May; 159(5):966-73. PubMed ID: 2540250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
    Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An in vitro investigation of the intraphagocytic bioactivity of difloxacin, ciprofloxacin, pefloxacin and fleroxacin.
    van Rensburg CE; Joone G; Anderson R
    Chemotherapy; 1989; 35(4):273-7. PubMed ID: 2504545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of roxithromycin and erythromycin on cellular immune functions in vitro. 3. Killing of intracellular Staphylococcus aureus by human macrophages.
    Cuffini AM; Carlone NA; Tullio V; Borsotto M
    Microbios; 1989; 58(234):27-33. PubMed ID: 2739587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postantibiotic effect of roxithromycin, erythromycin, and clindamycin against selected gram-positive bacteria and Haemophilus influenzae.
    Kuenzi B; Segessenmann C; Gerber AU
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():39-46. PubMed ID: 3501426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro activity of roxithromycin against respiratory and skin pathogens.
    Pechére JC; Auckenthaler R
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():1-5. PubMed ID: 3501424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro activity of roxithromycin (RU 28965) compared with four oral antibiotics.
    Drabu YJ; Mehtar S; Blakemore PH
    Drugs Exp Clin Res; 1987; 13(4):201-3. PubMed ID: 3622250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro comparison of roxithromycin and erythromycin against 900 anaerobic bacterial strains.
    Dubreuil L
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():13-9. PubMed ID: 3429381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antimicrobial activity of A-56268 (TE-031) and roxithromycin (RU965) against Legionella using broth microdilution method.
    Jones RN; Barry AL
    J Antimicrob Chemother; 1987 Jun; 19(6):841-2. PubMed ID: 2956231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.